Sonova (SONVY) Stock Price, News & Analysis

Company Overview

Sonova Holding AG is a Switzerland-based company focused on hearing care and hearing solutions. Through its businesses, the company develops, manufactures and distributes hearing aids, cochlear implants and other hearing-related technologies designed to help people with hearing loss communicate and participate more fully in daily life.

Sonova’s portfolio includes hearing instruments and accessories, wireless communication products, implantable hearing systems and audiological services. Its principal brands include Phonak, Unitron and Advanced Bionics, while its hearing-care retail and service operations operate under brands such as AudioNova and other regional names. The company also provides hearing tests, fitting, maintenance and related patient support through a network of professional outlets.

Founded in 1947 and headquartered in Stäfa, Switzerland, Sonova serves customers through sales and distribution operations in markets across Europe, North America, Asia-Pacific and other international regions. Arnd Kaldowski has served as Sonova’s chief executive officer since 2018.

Key Stats

• Today's Range: $55.40 to $56.42
• 50-Day Range: $49.25 to $61.04
• 52-Week Range: $42.26 to $61.04
• Volume: 11,804 shs
• Average Volume: 10,443 shs
• Market Capitalization: $16.55 billion
• P/E Ratio: N/A
• Dividend Yield: 1.22%
• Price Target: N/A
• Consensus Rating: Hold

Sonova Stock Analysis - MarketRank™

Sonova scored higher than 49% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.8 / 5
• Analyst Rating: Hold

Consensus Rating

Sonova has received a consensus rating of Hold. The company's average rating score is 2.43, and is based on 1 strong buy rating, 2 buy ratings, 3 hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Sonova has only been the subject of 3 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: 14.86%

Earnings Growth

Earnings for Sonova are expected to grow by 14.86% in the coming year, from $2.76 to $3.17 per share.

Price to Earnings Growth Ratio

Sonova has a PEG Ratio of 4.10. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Sonova has a P/B Ratio of 5.04. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.00% of the float of Sonova has been sold short.

Short Interest Ratio / Days to Cover

Sonova has a short interest ratio ("days to cover") of 0.28, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Sonova has recently decreased by 57.53%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Sonova pays a meaningful dividend of 1.23%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Sonova does not have a long track record of dividend growth.

Dividend Sustainability

Based on earnings estimates, Sonova will have a dividend payout ratio of 21.45% next year. This indicates that Sonova will be able to sustain or increase its dividend.

News and Social Media

• Score: 3.1 / 5
• News Sentiment: 0.99

News Sentiment

Sonova has a news sentiment score of 0.99. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.89 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Sonova this week, compared to 1 article on an average week.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Sonova insiders have not sold or bought any company stock.

Percentage Held by Insiders

0.01% of the stock of Sonova is held by insiders.

Percentage Held by Institutions

0.01% of the stock of Sonova is held by institutions.

Company Calendar

• Today: 9/14/2026
• Next Earnings (Estimated): 11/12/2026
• Fiscal Year End: 3/31/2027

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: OTCMKTS:SONVY
• CIK: 1450681
• Web: www.sonova.com
• Phone: (158) 928-0101
• Fax: 41-58-928-2011
• Employees: 18,447
• Year Founded: 1947

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 20.12
• P/E Growth: 4.1
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 0.51
• Current Ratio: 1.75
• Quick Ratio: 1.43

Sales & Book Value

• Annual Sales: $4.50 billion
• Price / Sales: 3.68
• Cash Flow: $3.79 per share
• Price / Cash Flow: 14.67
• Book Value: $11.03 per share
• Price / Book: 5.04

Miscellaneous

• Outstanding Shares: 298,040,000
• Free Float: 298,010,000
• Market Cap: $16.55 billion
• Optionable: Not Optionable
• Beta: 1.31